High-content confocal analysis of tumorigenesis, cancer stem cells, and drug response in 3D cholangiocarcinoma cultures

dc.contributor.authorKongtanawanich K.
dc.contributor.authorJamnongsong S.
dc.contributor.authorHokland M.
dc.contributor.authorWattanapanitch M.
dc.contributor.authorJirawatnotai S.
dc.contributor.correspondenceKongtanawanich K.
dc.contributor.otherMahidol University
dc.date.accessioned2025-09-02T18:29:08Z
dc.date.available2025-09-02T18:29:08Z
dc.date.issued2025-12-01
dc.description.abstractThree-dimensional (3D) culture models, particularly multi-spheroid models, are becoming increasingly essential in cancer drug discovery, particularly in stem cell and cancer stem cell (CSC) research. However, analytical methods for 3D multi-spheroid models, especially for single-cell and single-spheroid analysis in CSC research, remain limited. To address this gap we developed 3D multi-spheroid cholangiocarcinoma models that incorporate a CSC live-cell biosensor and a novel analysis method, 3D Surface Integrative Spheroid Profiling (3D-SiSP), utilizing high-content confocal imaging. 3D-SiSP quantifies spheroid area, allowing for both high- and low-throughput analyses. We demonstrate three key applications of 3D-SiSP. First, it outperformed traditional length-based methods for in vitro tumorigenesis measurements, offering greater precision. Second, 3D-SiSP enabled the calculation of individual spheroid areas along with real-time CSC biosensor signals, revealing larger spheroids had more undifferentiated cells. Lastly, 3D-SiSP facilitated simultaneous, real-time quantification of CSC content during anti-cancer drug testing in individual spheroids, providing evaluation of drug responses. Drug response differences across treatments were also quantified. Overall, 3D-SiSP provides a flexible and effective methodology for characterizing cancer cells and CSCs while evaluating anti-cancer drugs, applicable in both high- and low-throughput contexts. This approach enhances our understanding of CSC dynamics and supports the development of anti-CSC therapies.
dc.identifier.citationScientific Reports Vol.15 No.1 (2025)
dc.identifier.doi10.1038/s41598-025-16144-9
dc.identifier.eissn20452322
dc.identifier.scopus2-s2.0-105014192745
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/111930
dc.rights.holderSCOPUS
dc.subjectMultidisciplinary
dc.titleHigh-content confocal analysis of tumorigenesis, cancer stem cells, and drug response in 3D cholangiocarcinoma cultures
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105014192745&origin=inward
oaire.citation.issue1
oaire.citation.titleScientific Reports
oaire.citation.volume15
oairecerif.author.affiliationAarhus Universitet
oairecerif.author.affiliationSiriraj Hospital
oairecerif.author.affiliationSilpakorn University

Files

Collections